Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathways

Anxiety and depression are common non-motor symptoms of Parkinson’s disease (PD) that significantly affect patients’ quality of life. In recent years, our understanding of PD has advanced through multifaceted studies on the pathological mechanisms associated with anxiety and depression in PD. These...

Full description

Saved in:
Bibliographic Details
Main Authors: Jihu Zhao, Huafang Jia, Pengju Ma, Deyuan Zhu, Yibin Fang
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661825001422
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849744519500660736
author Jihu Zhao
Huafang Jia
Pengju Ma
Deyuan Zhu
Yibin Fang
author_facet Jihu Zhao
Huafang Jia
Pengju Ma
Deyuan Zhu
Yibin Fang
author_sort Jihu Zhao
collection DOAJ
description Anxiety and depression are common non-motor symptoms of Parkinson’s disease (PD) that significantly affect patients’ quality of life. In recent years, our understanding of PD has advanced through multifaceted studies on the pathological mechanisms associated with anxiety and depression in PD. These classic psychiatric symptoms involve complex pathophysiology, with both distinct features and connections to the mechanisms underlying the aetiology of PD. Furthermore, the co-occurrence of anxiety and depression in PD blurs the boundaries between them. Therefore, a comprehensive summary of the pathogenic mechanisms associated with anxiety and depression will aid in better addressing the emergence of these classic psychiatric symptoms in PD. This article integrates neuroanatomical, neural projection, neurotransmitter, neuroinflammatory, brain-gut axis, neurotrophic, hypothalamic-pituitary-adrenal axis, and genetic perspectives to provide a comprehensive description of the core pathological alterations underlying anxiety and depression in PD, aiming to provide an up-to-date perspective and broader therapeutic prospects for PD patients suffering from anxiety or depression.
format Article
id doaj-art-5a5a1d22e63d445fab864e5cb80dfd8a
institution DOAJ
issn 1096-1186
language English
publishDate 2025-05-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj-art-5a5a1d22e63d445fab864e5cb80dfd8a2025-08-20T03:14:08ZengElsevierPharmacological Research1096-11862025-05-0121510771710.1016/j.phrs.2025.107717Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathwaysJihu Zhao0Huafang Jia1Pengju Ma2Deyuan Zhu3Yibin Fang4Translational Research Institute of Brain and Brain-Like Intelligence, Department of Neurovascular Disease, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaQingdao Medical College of Qingdao University, Qingdao, Shandong, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, ChinaTranslational Research Institute of Brain and Brain-Like Intelligence, Department of Neurovascular Disease, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China; Corresponding authors.Translational Research Institute of Brain and Brain-Like Intelligence, Department of Neurovascular Disease, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China; Corresponding authors.Anxiety and depression are common non-motor symptoms of Parkinson’s disease (PD) that significantly affect patients’ quality of life. In recent years, our understanding of PD has advanced through multifaceted studies on the pathological mechanisms associated with anxiety and depression in PD. These classic psychiatric symptoms involve complex pathophysiology, with both distinct features and connections to the mechanisms underlying the aetiology of PD. Furthermore, the co-occurrence of anxiety and depression in PD blurs the boundaries between them. Therefore, a comprehensive summary of the pathogenic mechanisms associated with anxiety and depression will aid in better addressing the emergence of these classic psychiatric symptoms in PD. This article integrates neuroanatomical, neural projection, neurotransmitter, neuroinflammatory, brain-gut axis, neurotrophic, hypothalamic-pituitary-adrenal axis, and genetic perspectives to provide a comprehensive description of the core pathological alterations underlying anxiety and depression in PD, aiming to provide an up-to-date perspective and broader therapeutic prospects for PD patients suffering from anxiety or depression.http://www.sciencedirect.com/science/article/pii/S1043661825001422Parkinson’s diseaseAnxietyDepressionClinical imagingMolecular mechanismTargeted therapy
spellingShingle Jihu Zhao
Huafang Jia
Pengju Ma
Deyuan Zhu
Yibin Fang
Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathways
Pharmacological Research
Parkinson’s disease
Anxiety
Depression
Clinical imaging
Molecular mechanism
Targeted therapy
title Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathways
title_full Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathways
title_fullStr Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathways
title_full_unstemmed Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathways
title_short Multidimensional mechanisms of anxiety and depression in Parkinson’s disease: Integrating neuroimaging, neurocircuits, and molecular pathways
title_sort multidimensional mechanisms of anxiety and depression in parkinson s disease integrating neuroimaging neurocircuits and molecular pathways
topic Parkinson’s disease
Anxiety
Depression
Clinical imaging
Molecular mechanism
Targeted therapy
url http://www.sciencedirect.com/science/article/pii/S1043661825001422
work_keys_str_mv AT jihuzhao multidimensionalmechanismsofanxietyanddepressioninparkinsonsdiseaseintegratingneuroimagingneurocircuitsandmolecularpathways
AT huafangjia multidimensionalmechanismsofanxietyanddepressioninparkinsonsdiseaseintegratingneuroimagingneurocircuitsandmolecularpathways
AT pengjuma multidimensionalmechanismsofanxietyanddepressioninparkinsonsdiseaseintegratingneuroimagingneurocircuitsandmolecularpathways
AT deyuanzhu multidimensionalmechanismsofanxietyanddepressioninparkinsonsdiseaseintegratingneuroimagingneurocircuitsandmolecularpathways
AT yibinfang multidimensionalmechanismsofanxietyanddepressioninparkinsonsdiseaseintegratingneuroimagingneurocircuitsandmolecularpathways